Article Text

PDF
Commentary: Shoot the renals!
  1. F C Luft,
  2. C M Gross
  1. 1
    Medical Faculty of the Charité, Franz-Volhard Clinic, HELIOS Klinikum Berlin-Brandenburg, Berlin, Germany
  1. Dr F C Luft, Experimental and Clinical Research Centre, Lindenberger Weg 80, 13125 Berlin, Germany; Luft{at}charite.de

Abstract

Atherosclerotic renal artery stenosis (ARAS) is a growing dilemma. The condition is increasingly common and can promulgate hypertension and result in renal failure. However, patients with ARAS generally die owing to their coronaries or cerebral vessels. Intervention, by stenting or angioplasty is beloved and believed, but not proved. The American Heart Association has recently published guidelines regarding patients at high risk for ARAS who are potential candidates for revascularisation. Since this phraseology includes practically every patient with atherosclerosis, these guidelines appear ill advised.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None declared.

  • Abbreviations:
    AHA
    American Heart Association
    ARAS
    atherosclerotic renal artery stenosis
    CORAL
    Cardiovascular Outcomes in Renal Atherosclerotic Lesions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles